Visgenx develops therapeutics to protect against the loss of sight from retinal disorders. Its programs are based on increasing the expression of a gene known as ELOVL2 which may regulate aging in cells critical for vision.

Biotechnology

Health Care

Therapeutics

Visgenx, Inc

Visgenx, Inc's headquarters in San Diego, CA, United States

This department focuses on advancing scientific knowledge and innovation in new products and technologies.

Research and Development

This department provides strategic direction and oversight for the organization, guiding decision-making at the highest level.

People (0)

Jobs (0)

Other teams

Executive Leadership